elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26752815-19267B6F-2DE6-4DE9-886B-A226F4182799
Q26752815-19267B6F-2DE6-4DE9-886B-A226F4182799
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752815-19267B6F-2DE6-4DE9-886B-A226F4182799
Sodium-glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metformin
P2860
Q26752815-19267B6F-2DE6-4DE9-886B-A226F4182799
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752815-19267B6F-2DE6-4DE9-886B-A226F4182799
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a786038d0bb2f2f3f87a7eb927aa3d00a963fb1
P2860
Glucose control and vascular complications in veterans with type 2 diabetes